Skip to main content
Log in

Adjunctive CBT: cost effective in tx-resistant depression

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Hollinghurst S, et al. Cost-effectiveness of cognitive-behavioural therapy as an adjunct to pharmacotherapy for treatment-resistant depression in primary care: economic evaluation of the CoBalT Trial. British Journal of Psychiatry : 12 Nov 2013. Available from: URL: http://dx.doi.org/10.1192/bjp.bp.112.125286

    PubMed  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adjunctive CBT: cost effective in tx-resistant depression. PharmacoEcon Outcomes News 693, 4 (2013). https://doi.org/10.1007/s40274-013-0926-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40274-013-0926-0

Navigation